Cancer News and Research

Latest Cancer News and Research

State-of-the-art HIV vaccine laboratory opens in Cape Town, South Africa

Fred Hutchinson Cancer Research Center tomorrow will celebrate the grand opening of a state-of-the-art HIV vaccine laboratory in Cape Town, South Africa.

24 Oct 2013

New imaging tool could someday be used for routine breast cancer screenings

Breast cancer is one of the most common forms of cancer and cancer deaths among women worldwide. Routine screening can increase breast cancer survival by detecting the disease early and allowing doctors to address it at this critical stage.

23 Oct 2013

A simple blood test may reveal the earliest signs of pancreatic cancer

Reporting on a small preliminary study, Johns Hopkins researchers say a simple blood test based on detection of tiny epigenetic alterations may reveal the earliest signs of pancreatic cancer, a disease that is nearly always fatal because it isn't usually discovered until it has spread to other parts of the body.

23 Oct 2013

Imugene Acquiring Biolife, As Lead Pipeline Candidate Nears Phase II

...

23 Oct 2013

Cleveland Biolabs Subsidiary Awarded $4.6M Russian Contract

...

23 Oct 2013

The Melting Pot, St. Jude Children's Research Hospital partner to raise funds for cancer research

The Melting Pot Restaurants, Inc., the world's premier fondue restaurant franchise, is partnering with St. Jude Children's Research Hospital for the 10th annual St. Jude Thanks and Giving campaign from Oct. 19 - Dec. 15, that asks guests to "give to help the children of St. Jude live" by raising funds for cancer research.

23 Oct 2013

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

In a move to address a significant unmet need in hepatitis C in Canada, the University Health Network, together with Boehringer Ingelheim (Canada) Ltd., announced today a multi-year partnership that aims to improve care, education and support for patients with hepatitis C. The program, known as Link-C, aims to improve access to hepatitis C care and treatment in remote areas of Ontario and other parts of Canada.

23 Oct 2013

FDA grants Priority Review to Lilly's ramucirumab for treatment of advanced gastric cancer

Eli Lilly and Company today announced that the U.S. Food and Drug Administration has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy.

23 Oct 2013

Promising technique for treating eye disease proves effective in preclinical studies

A promising technique for treating human eye disease has proven effective in preclinical studies and may lead to new treatments to prevent blindness, according to experiments conducted at The Scripps Research Institute in La Jolla, California.

23 Oct 2013

Scientists reveal first comprehensive genomic analysis of aggressive lymphomas

Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas.

23 Oct 2013

Scientists create artificial protein that mimics key site on the outer coat of HIV

A team of scientists at Duke Medicine and Memorial Sloan-Kettering Cancer Center has created an artificial protein coupled with a sugar molecule that mimics a key site on the outer coat of HIV where antibodies can bind to neutralize a wide variety of HIV strains.

23 Oct 2013

EORTC/GIMEMA trial shows combination of GO and chemotherapy provides no benefit for older patients with AML

Results of the randomized, phase III, EORTC/GIMEMA 06012 intergroup trial (AML-17) reported in the Journal of Clinical Oncology show that sequential combination of gemtuzumab ozogamicin (GO) and standard chemotherapy provides no benefit for older patients with acute myeloid leukemia (AML) and is too toxic for patients 70 years of age or more. GO is an antibody-drug conjugate comprised of an anti-CD33 monoclonal antibody linked to a cytotoxic agent.

23 Oct 2013

Functional biomarker could help guide treatment of patients with BRAF-mutant melanomas

A functional biomarker that can predict whether BRAF-mutant melanomas respond to drugs targeting BRAF could help guide the treatment of patients with these cancers, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.

23 Oct 2013

Homeless people are extremely frequent users of health services, finds research

Single women who are homeless visit a hospital Emergency Department an average of more than twice a year, 13 times more often than women in the general population, new research has found.

23 Oct 2013

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

23 Oct 2013

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

A new diagnostic platform to detect BRAF mutations in melanoma and other cancer types is faster and more accurate compared with the standard method currently used in clinics, and this could help accelerate diagnosis and treatment, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

23 Oct 2013

FDA seeks permanent injunction against dietary supplement manufacturer James G. Cole

The U.S. Food and Drug Administration, in a complaint filed by the U.S. Department of Justice, is seeking a permanent injunction against the dietary supplement manufacturer James G. Cole, Inc., its president, James G. Cole, and its general manager, Julie D. Graves, following the company's repeated distribution of unapproved drugs and adulterated dietary supplements in violation of the Federal Food, Drug, and Cosmetic Act.

23 Oct 2013

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.

23 Oct 2013

Carcinogens detected in emissions downwind of 'Industrial Heartland'

Levels of contaminants higher than in some of the world's most polluted cities have been found downwind of Canada's largest oil, gas and tar sands processing zone, in a rural area where men suffer elevated rates of cancers linked to such chemicals.

23 Oct 2013

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

IBM scientists are collaborating with pathologists at the University Hospital Zurich to test a new prototype tool to accurately diagnose different types of cancer. This work is based on a technology developed by IBM scientists called a microfluidic probe, which slightly resembles the nib of a fountain pen.

23 Oct 2013

Cancer News and Research

Latest Cancer News and Research

State-of-the-art HIV vaccine laboratory opens in Cape Town, South Africa

New imaging tool could someday be used for routine breast cancer screenings

A simple blood test may reveal the earliest signs of pancreatic cancer

Imugene Acquiring Biolife, As Lead Pipeline Candidate Nears Phase II

Cleveland Biolabs Subsidiary Awarded $4.6M Russian Contract

The Melting Pot, St. Jude Children's Research Hospital partner to raise funds for cancer research

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

FDA grants Priority Review to Lilly's ramucirumab for treatment of advanced gastric cancer

Promising technique for treating eye disease proves effective in preclinical studies

Scientists reveal first comprehensive genomic analysis of aggressive lymphomas

Scientists create artificial protein that mimics key site on the outer coat of HIV

EORTC/GIMEMA trial shows combination of GO and chemotherapy provides no benefit for older patients with AML

Functional biomarker could help guide treatment of patients with BRAF-mutant melanomas

Homeless people are extremely frequent users of health services, finds research

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

FDA seeks permanent injunction against dietary supplement manufacturer James G. Cole

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

Carcinogens detected in emissions downwind of 'Industrial Heartland'

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in